Lux Ventures Iv, L.P. Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity
Lux Ventures Iv, L.P. is of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 13 Million shares of RXRX, which is worth approximately $74.2 Million. The most recent transaction as insider was on Dec 07, 2021, when has been sold 4,265,576 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13M
0%
3M change
0%
12M change
Total Value Held
$74.2 Million
Lux Ventures IV, L.P. Transaction History
Also insider at
LVI
Lux Ventures Iv, L.P.
New York, NY